drugset / Trial / NCT03142204
[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy
Phase 1
Unknown
30 enrolled
CellSight Technologies, Inc.
UCSF Imaging Center at China Basin · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This is a Phase 1 study is to visualize biodistribution of a PET tracer called \[18F\]F-AraG (VisAcT) in cancer patients expected to undergo immunotherapy and/or radiation therapy.
Timeline
- Start
- 2017-05-01
- Primary completion
- 2024-05
- Completion
- 2024-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | F-ARAG | Diagnostic / imaging agent | — | Intravenous |